• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    5/15/23 1:45:31 PM ET
    $ACHR
    $AI
    $ALGS
    $ANTE
    Aerospace
    Industrials
    Computer Software: Prepackaged Software
    Technology
    Get the next $ACHR alert in real time by email

    Gainers

    • NeoGames S.A. (NASDAQ:NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
    • 1847 Holdings LLC (NASDAQ:EFSH) gained 64.5% to $0.9050 after the company reported a 27.6% increase in revenue to $15.4 million and achieved profitability for the first quarter.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) surged 49.5% to $8.97 following first-quarter results.
    • WiSA Technologies, Inc. (NASDAQ:WISA) rose 47.4% to $2.33 after the company signed a Letter of Intent to acquire Comhear. WiSA expects acquisition to be accretive beginning in the fourth quarter and sees FY24 revenue of $10 million to $15 million.
    • Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) gained 39% to $3.94 as the company said that its Chinese partner, HTIT, has successfully completed a Phase 3 oral insulin clinical trial and submitted a marketing authorization application in China.
    • LM Funding America, Inc. (NASDAQ:LMFA) jumped 34% to $0.9816 following better-than-expected results for the first quarter.
    • MGO Global, Inc. (NASDAQ:MGOL) shares gained 33.2% to $1.5910. MGO Global is scheduled to host a webcast on May 16, 2023 to discuss recent operational developments and financial results for the first quarter.
    • Xenetic Biosciences, Inc. (NASDAQ:XBIO) jumped 24.8% to $4.12. Xenetic Biosciences recently announced a 1-for-10 reverse stock split.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) gained 24% to $148.99 after the company announced the FDA voted in favor of its gene therapy to treat Duchenne muscular dystrophy late Friday. Multiple analysts raised price targets following the announcement.
    • Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) surged 22% to $2.50.
    • ZK International Group Co., Ltd. (NASDAQ:ZKIN) gained 21.7% to $0.7790.
    • Peraso Inc. (NASDAQ:PRSO) shares climbed 18.1% to $0.4263. Peraso is expected to release its first-quarter financial results on May 15, 2023 after the closing bell.
    • InspireMD, Inc. (NASDAQ:NSPR) jumped 18% to $1.71 as the company announced a private placement of up to $113.6 million.
    • DBV Technologies S.A. (NASDAQ:DBVT) gained 17.7% to $2.33.
    • ImmunityBio, Inc. (NASDAQ:IBRX) gained 16% to $2.6400.
    • Latham Group, Inc. (NASDAQ:SWIM) rose 15.3% to $3.84.
    • Magellan Midstream Partners, L.P. (NYSE:MMP) surged 15.1% to $63.78 after the company announced it would merge with ONEOK.
    • Aligos Therapeutics, Inc. (NASDAQ:ALGS) shares gained 14.7% to $1.25 after the company reported a Research collaboration and development agreement with Xiamen Amoytop Biotech Co. Ltd. for the use of Aligos’ oligonucleotide platform for the treatment of liver diseases.
    • Twist Bioscience Corporation (NASDAQ:TWST) rose 14.3% to $13.66.
    • Eastside Distilling, Inc. (NASDAQ:EAST) surged 13.3% to $4.26 after posting a narrower-than-expected quarterly loss.
    • Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) gained 13% to $6.80.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) jumped 12.5% to $7.16.
    • monday.com Ltd. (NASDAQ:MNDY) rose 12.6% to $147.70 after the company announced 2023 revenue expectations above analyst estimates.
    • Autolus Therapeutics plc (NASDAQ:AUTL) gained 12.2% to $2.30.
    • Archer Aviation Inc. (NYSE:ACHR) rose 11.9% to $2.2385. Archer Aviation recently reported worse-than-expected Q1 EPS results.
    • MIND Technology, Inc. (NASDAQ:MIND) rose 11.3% to $0.4563 after the company announced its Seamap unit has received an additional order for a GunLink source control system for delivery later this fiscal year. The order has a total value of approximately $3.1 million.
    • Telos Corporation (NASDAQ:TLS) gained 12.1% to $2.50. Lp Resilient Services JV LLC said it has been awarded a Small Business Technology Transfer (STTR) Phase II contract by the United States Air Force (USAF) AFWERX program.
    • C3.ai, Inc. (NYSE:AI) rose 10.5% to $21.46 after the company reported strong preliminary financial results.
    • HEICO Corporation (NYSE:HEI) gained 7.7% to $178.85. HEICO agreed to acquire Wencor Group from affiliates of Warburg Pincus LLC and Wencor's management.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) gained 6.5% to $0.1889 ahead of quarterly results.

    Losers

    • Athenex, Inc. (NASDAQ:ATNX) fell 63.2% to $0.42 after the company announced it voluntarily filed Chapter 11 proceedings.
    • Exela Technologies, Inc. (NASDAQ:XELA) shares fell 46.6% to $2.68. Exela Technologies, on Friday, announced a 1-for-200 reverse stock split.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) dropped 39.5% to $0.7863.
    • ImmunoPrecise Antibodies Ltd. (NYSE:IPA) fell 25.7% to $3.00.
    • Jaguar Health, Inc. (NASDAQ:JAGX) declined 24.7% to $0.7379. Jaguar Health posted a first-quarter loss of $2.39 per share.
    • Babylon Holdings Limited (NASDAQ:BBLN) dropped 23% to $0.8240.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) fell 22% to $3.95 after the company reported preliminary top-line data from the Phase 2 trial's 25 mg cohort. The company also reported Q1 financial results.
    • DIRTT Environmental Solutions Ltd. (NASDAQ:DRTT) dropped 19.8% to $0.3608.
    • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) fell 18.7% to $4.05.
    • Ocuphire Pharma, Inc. (NASDAQ:OCUP) dipped 18.5% to $4.9115 following weak quarterly results.
    • Impel Pharmaceuticals Inc. (NASDAQ:IMPL) fell 17.7% to $1.25. Impel Pharmaceuticals recently reported a decrease in year-over-year Q1 EPS results and worse-than-expected Q1 sales results.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) fell 16.5% to $3.20 after jumping over 25% on Friday.
    • NovaBay Pharmaceuticals, Inc. (NYSE:NBY) fell 15.8% to $0.8183.
    • AirNet Technology Inc. (NASDAQ:ANTE) declined 15.7% to $1.02.
    • Venus Concept Inc. (NASDAQ:VERO) dropped 15.5% to $3.6182 after reporting a loss for the first quarter.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) declined 15.2% to $0.6202. Sunshine Biopharma recently announced pricing of a $5 million private placement priced at-the-market.
    • Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) fell 14.3% to $5.70 after jumping around 30% on Friday.
    • Blue Bird Corporation (NASDAQ:BLBD) dropped 12.2% to $23.11. Blue Bird said that Phil Horlock will again lead the company as CEO.
    • TH International Limited (NASDAQ:THCH) declined 10.3% to $3.20.
    • Wearable Devices Ltd. (NASDAQ:WLDS) shares fell 9.2% to $0.4624 after climbing over 10% on Friday.
    • OraSure Technologies, Inc. (NASDAQ:OSUR) dropped 9.1% to $5.46.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) fell 8.1% to $2.40. Dermata Therapeutics shares jumped 35% on Friday after the company provided a corporate update and reported Q1 financial results.
    • NextNav Inc. (NASDAQ:NN) fell 7.1% to $2.62.
    • ONEOK, Inc. (NYSE:OKE) shares fell 6.2% to $59.80 after the company announced plans to acquire Magellan Midstream Partners in a transaction valued at $18.8 billion.

    Now Read This: Ethereum Tops $1,800; Conflux Emerges As Top Gainer

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $AI
    $ALGS
    $ANTE

    CompanyDatePrice TargetRatingAnalyst
    Heico Corporation
    $HEI
    2/27/2026Neutral → Outperform
    BNP Paribas Exane
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    ONEOK Inc.
    $OKE
    2/25/2026Outperform → Peer Perform
    Wolfe Research
    monday.com Ltd.
    $MNDY
    2/23/2026$80.00Buy → Hold
    Jefferies
    Autolus Therapeutics plc
    $AUTL
    2/17/2026$9.00Buy
    H.C. Wainwright
    Great Lakes Dredge & Dock Corporation
    $GLDD
    2/12/2026Outperform → Market Perform
    Noble Capital Markets
    monday.com Ltd.
    $MNDY
    2/10/2026$80.00Buy → Hold
    Loop Capital
    monday.com Ltd.
    $MNDY
    2/10/2026$90.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ACHR
    $AI
    $ALGS
    $ANTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HEICO upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded HEICO from Neutral to Outperform

    2/27/26 8:21:04 AM ET
    $HEI
    Aerospace
    Industrials

    C3.ai downgraded by Citizens

    Citizens downgraded C3.ai from Mkt Outperform to Mkt Perform

    2/26/26 7:10:22 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    ONEOK downgraded by Wolfe Research

    Wolfe Research downgraded ONEOK from Outperform to Peer Perform

    2/25/26 8:54:43 AM ET
    $OKE
    Oil & Gas Production
    Utilities

    $ACHR
    $AI
    $ALGS
    $ANTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here "We are delighted to highlight today's innovators from the Life Science

    3/10/26 10:21:44 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    Archer's US Air Taxi Operations Take Major Step Forward as Florida, New York and Texas Selected for White House Pilot Program

    The US Department of Transportation and Federal Aviation Administration announced today that Archer's partners in Texas, Florida and New York were selected for the White House's eVTOL Integration Pilot Program, a major step toward bringing air taxis to market in the United States. The program creates a first-of-its-kind pathway to help bring the first new category of aircraft in nearly 80 years to market. Archer will now work directly with partners in Texas, Florida and New York to begin laying the groundwork for early Midnight operations in those states as soon as the second half of 2026. The speed at which the DOT and FAA are rolling out this program signals the importance the U

    3/9/26 3:21:00 PM ET
    $ACHR
    Aerospace
    Industrials

    InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, March 09, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its fourth quarter and full year 2025 financial results on Wednesday, March 18, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD's corporate website at https://investors.inspiremd.com. Interested participants are encouraged to register more than 15 minutes before the star

    3/9/26 9:00:00 AM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    $ACHR
    $AI
    $ALGS
    $ANTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    * Director by Deputization Flynn James E bought $25,000,000 worth of shares (5,000,000 units at $5.00) (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 7:46:04 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hamilton Thomas Edward bought $500,000 worth of shares (100,000 units at $5.00), increasing direct ownership by 18% to 664,798 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:41 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Thomas Frank E bought $25,000 worth of shares (5,000 units at $5.00), increasing direct ownership by 250% to 7,000 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:36 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AI
    $ALGS
    $ANTE
    SEC Filings

    View All

    SEC Form 10-K filed by OraSure Technologies Inc.

    10-K - ORASURE TECHNOLOGIES INC (0001116463) (Filer)

    3/9/26 4:29:14 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Larimar Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Larimar Therapeutics, Inc. (0001374690) (Filer)

    3/9/26 4:08:31 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunshine Biopharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    3/9/26 4:05:28 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AI
    $ALGS
    $ANTE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AI
    $ALGS
    $ANTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by C3.ai Inc.

    4 - C3.ai, Inc. (0001577526) (Issuer)

    3/10/26 6:41:12 PM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    President & CEO Harr Steve covered exercise/tax liability with 24,345 shares and converted options into 91,666 shares, increasing direct ownership by 0.85% to 7,944,251 units (SEC Form 4)

    4 - Sana Biotechnology, Inc. (0001770121) (Issuer)

    3/10/26 4:16:12 PM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Wyrick Susan D. converted options into 13,666 shares and covered exercise/tax liability with 4,387 shares, increasing direct ownership by 5% to 196,196 units (SEC Form 4)

    4 - Sana Biotechnology, Inc. (0001770121) (Issuer)

    3/10/26 4:15:55 PM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHR
    $AI
    $ALGS
    $ANTE
    Leadership Updates

    Live Leadership Updates

    View All

    NextNav Appoints Lisa Hook to Board of Directors

    NextNav Expands Board with Appointment of Seasoned Technology and National Security Leader NextNav Inc. (NASDAQ:NN), a leader in next-generation terrestrial Positioning, Navigation, and Timing (PNT) and 3D geolocation solutions, today announced the appointment of Lisa Hook to its Board of Directors, effective February 24, 2026. Ms. Hook will also serve as Lead Independent Director and has been appointed as a member of the Company's Technology and National Defense and Compensation and Human Capital Committees. "I am delighted to welcome Lisa to the NextNav Board of Directors," said Mariam Sorond, NextNav's Chief Executive Officer and Board Chair. "Her leadership in global information ser

    2/27/26 11:53:00 AM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

    SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as Executive Vice President, Chief Financial Officer. Mr. Piper brings to Sana a breadth of biopharmaceutical financial and operational expertise with over 25 years of experience in various positions in the industry. Mr. Piper was most recently CFO of Scorpion Therapeutics and its post-acquisition spin-off, Antares Therapeutics. "I am thrilled to welcome Brian to Sana and to our leadership team," said Steve Harr, President and Chief Executive Officer of Sana. "He brings deep exper

    2/17/26 9:00:00 AM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Great Lakes Dredge & Dock to Join the Saltchuk Family of Companies

    HOUSTON and SEATTLE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the "Company") (NASDAQ:GLDD), the largest provider of dredging services in the United States, and Saltchuk Resources, Inc. ("Saltchuk"), a privately owned family of diversified freight transportation, marine service, and energy distribution companies, today announced a definitive agreement for Saltchuk to acquire Great Lakes at an aggregate equity value of approximately $1.2 billion and a total transaction value of $1.5 billion. Under the terms of the agreement, which has been unanimously approved by the Board of Directors of both companies, Saltchuk will commence a tender offer

    2/11/26 7:30:00 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    $ACHR
    $AI
    $ALGS
    $ANTE
    Financials

    Live finance-specific insights

    View All

    InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, March 09, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its fourth quarter and full year 2025 financial results on Wednesday, March 18, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD's corporate website at https://investors.inspiremd.com. Interested participants are encouraged to register more than 15 minutes before the star

    3/9/26 9:00:00 AM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    SOUTH SAN FRANCISCO, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on March 12, 2026 at 4:30 pm ET (1:30 pm PT) to provide a business update and report fourth quarter 2025 financial results. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus' website for 90 d

    3/5/26 4:01:00 PM ET
    $CRVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Latham Group, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

    Strong Fourth Quarter and Full Year Results as Latham Continued to Outperform the U.S. In-Ground Pool Market Year-on-Year Margin Expansion Reflected Lower Cost Structure and Cost Discipline, While Increasing Investments to Drive Future GrowthIn February 2026, Latham Acquired Freedom Pools, Significantly Expanding Australia/New Zealand Market Position; Transaction is Expected to be Immediately Accretive to Earnings2026 Guidance Anticipates 9.0% Net Sales Growth and 12.7% Adjusted EBITDA Growth at the Midpoints Fourth Quarter 2025 Financial Highlights: Net sales of $100.0 million up 14.5%Net loss of $7.0 million / Net loss per diluted share of $0.06 vs. net loss per diluted share of $0.25 i

    3/3/26 4:05:00 PM ET
    $SWIM
    Plastic Products
    Industrials

    $ACHR
    $AI
    $ALGS
    $ANTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by InspireMD Inc.

    SC 13G - InspireMD, Inc. (0001433607) (Subject)

    12/4/24 4:31:06 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary